Some non-conventional biomolecular targets for diamidines. A short survey

This publication has 100 references indexed in Scilit:

• Design of a Bioactive Small Molecule That Targets the Myotonic Dystrophy Type 1 RNA via an RNA Motif–Ligand Database and Chemical Similarity Searching
  Journal of the American Chemical Society, 2012
• Current Chemical Biology Approaches to Interrogate Protein Methyltransferases
  ACS Chemical Biology, 2012
• Therapeutics development in myotonic dystrophy type 1
  Muscle & Nerve, 2011
• Interactome Networks and Human Disease
  Cell, 2011
• Polyamine pathway contributes to the pathogenesis of Parkinson disease
  Proceedings of the National Academy of Sciences, 2010
• Pentamidine reverses the splicing defects associated with myotonic dystrophy
  Proceedings of the National Academy of Sciences, 2009
• Structure and Inhibition of Human Diamine Oxidase
  Biochemistry, 2009
• Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication
  Nucleic Acids Research, 2008
• Targeting PTPs with small molecule inhibitors in cancer treatment
  Cancer and Metastasis Reviews, 2008
• Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
  Nucleic Acids Research, 2007